期刊文献+

联合筛查和单一细胞学筛查宫颈癌的比较分析 被引量:2

Comparative analysis of packaging screening and single cytological screening for cervical cancer
下载PDF
导出
摘要 目的:比较宫颈癌的两种筛查方式,提高宫颈癌筛查的阳性率,降低漏诊率。方法:选取2016-2018年参加宫颈癌筛查的女性患者4744例,其中2359例采用液基薄层细胞学筛查(TCT),2385例行联合筛查[TCT+人乳头瘤病毒(HPV)病毒检测]。比较两组筛查结果。结果:联合筛查组检出HPV阳性273例,检出率为11.45%。两组细胞学筛查宫颈异常病例比较,差异无统计学意义(P>0.05)。根据阴道镜第三阶梯的诊断,联合筛查组HSIL病变检出率明显高于单一细胞学筛查组,差异有统计学意义(P<0.05)。结论:联合筛查对HSIL宫颈病变的检出率明显高于单一细胞学筛查,虽然成本较高,但筛查间隔的时间较长,且可以指导HPV疫苗的接种。 Objective:To compare the two screening methods of cervical cancer,improve the positive rate of cervical cancer screening and reduce the rate of missed diagnosis.Methods:From 2016 to 2018,4744 cases of patients who received cervical cancer screening were enrolled,among them,2359 cases were screened by liquid-based thin-layer cytology test(TCT),2385 cases were screened by packaging screening(TCT and HPV virus detection).The screening results between the two groups was compared.Results:273 cases tested positive for HPV by packaging screening,the detection rate was 11.45%.The cases of cervical abnormal of the two groups was compared,the difference was not statistically significant(P>0.05).According to the diagnosis of the third step of colposcopy,the detection rate of HSIL lesions in packaging screening group was significantly higher than that in single cytological screening group,the difference was statistically significant(P<0.05).Conclusion:The detection rate of packaging screening for HSIL cervical lesions is significantly higher than that of single cytological screening,although the cost is high,but the time interval of screening is longer and it can guide the HPV vaccination.
作者 杨丽丽 陈心俊 Yang Lili;Chen Xinjun(Department of Obstetrics and Gynecology,Shiqiao Central Health Center of Hi-tech Zone of Zibo City,Shandong Province,Shandong Zibo 255086)
出处 《中国社区医师》 2020年第25期41-42,共2页 Chinese Community Doctors
关键词 宫颈癌 单一细胞学筛查 筛查 Cervical cancer Single cytological screening Screening
  • 相关文献

参考文献7

二级参考文献47

  • 1贺昕红,蔺莉.绝经后妇女宫颈细胞学检查异常的临床分析[J].中国全科医学,2009,12(15):1390-1391. 被引量:11
  • 2李隆玉,乔志强,张燕玲.不同病理类型宫颈癌发病年龄趋势的初步观察[J].中国肿瘤临床,2007,34(6):338-340. 被引量:15
  • 3李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 4Gravitt P,Coutlee F,Iftner T,et al.New technologies in cervical cancer screening.Vaccine,2008,26 Suppl 10:K42-52.
  • 5Anttila A,Pukkala E,S(o)dennan B,et al.Effect of organized screening on cervical cancer incidence and mortality in Finland,1963-1995; recent increase in cervical cancer incidence.Int J Cancer,1999,83:59-65.
  • 6Belinson J,Qiao YL,Pretorius R,et al.Prevalence of cervical cancer and feasibility of screening in rural China:a pilot study for the Shanxi Province Cervical Cancer Screening Study.Int J Gynecol Cancer,1999,9:411-417.
  • 7Belinson J,Qiao YL,Pretorius R,et al.Shanxi Province Cervical Cancer Screening Study; a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia.Gynecol Oncol,2001,83:439-444.
  • 8Arbyn M,Sasieni P,Meijer CJ,et al.Chapter 9:Clinical applications of HPV testing:a summary of meta-analyses.Vaccine,2006,24 Suppl 3:S3/78-89.
  • 9Moss S,Gray A,Legood R,et al.Effect of testing for human papillomavirus as a triage during screening for cervical cancer:observational before and after study.BMJ,2006,332:83-85.
  • 10Cuzick J,Szarewski A,Mesher D,et al.Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology:results from the Hammersmith study.Int J Cancer,2008,122:2294-2300.

共引文献143

同被引文献13

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部